| Lot Release Number |
2020-01-15-0008
|
| FDA Registered Product/Generic Name |
Diphtheria, Tetanus and Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus influenzae Type B Conjugate Vaccine, Adsorbed
|
| Brand Name |
Infanrix-IPV+Hib
|
| Dosage Strength |
0.5 mL
|
| Dosage Form |
Suspension for Injection (Deep I.M.), 2 PE Free
|
| Registration Number |
BR-659
|
| Batch/Lot Number |
A20CB558 (DTPa-IPV: AC20B395A; HiB: AHIBD393C)
|
| Packaging Lot |
Packaging lot (box): A20CB558A
Pre-filled syringe: A20CB558A, ED 08-2021
Vial: A20FB558A, MD 07-2019, ED 06-2022;
Needles (25G x 1"): 1908009, ED 2024-07-31
|
| Product Expiration Date |
31 August 2021
|
| Issuance Date |
17 January 2020
|